In fact, the company offers 20mn shares (10%) of Syngene to public and reserved 2mn sharesforBioconShareholders.ItplanstooffersharestoBioconshareholdersandretail investorsatadiscounttoofferprice.PostissueBioconwillhold74.5%stakeinSyngene....